Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NDI. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112680497A reveals enzymatic splitting for high-purity Corey lactone. Achieve significant cost reduction in API intermediate manufacturing and supply reliability.
Patent CN109096162B details a mild Scandium(III) catalyzed synthesis of sulfur-containing intermediates, offering cost reduction in API manufacturing and scalable production.
Patent CN115850216B reveals Rh-catalyzed route. Green water solvent ensures high purity and supply chain stability for global buyers.
Discover the advanced CN113548993B patent method for Carboprost. Achieve 99%+ purity without chromatography. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Patent CN113773243B introduces a green catalytic process for isoindigo compounds enabling cost reduction in electronic material manufacturing with high-purity output.
Solve toxic AIBN risks in oxindole synthesis. Iron-catalyzed method cuts costs, ensures 75% yield, and enables scalable production for pharma intermediates. Contact for COA/MSDS.
Discover how copper-catalyzed synthesis of benzofuro[2,3-b]quinoline derivatives achieves 96% yield at 100°C, reducing production costs and supply chain risks for pharmaceutical manufacturers.
Discover a cost-effective, high-yield synthesis for Sacubitril intermediates with >99% purity and >98% ee, eliminating isomer impurities and supply chain risks.
Discover how novel biphenyl-type tridentate ligand ruthenium complexes enable ester-to-alcohol hydrogenation at 60-100°C and 3-10MPa, reducing costs and safety risks for pharma production.
Discover how NHC-catalyzed trifluoromethyl homoisoflavone synthesis reduces production costs, improves yield, and ensures supply chain stability for pharmaceutical intermediates.
Discover a cost-effective, scalable synthesis method for 3-trifluoromethyl-1,2,4-triazole compounds with high yields. Ideal for pharmaceutical R&D and production.
Discover a novel antitumor compound synthesis with 92-99% yield, mild conditions, and strong HONE-1 cytotoxicity. Optimize your drug development supply chain.
Discover high-yield phosphabenzopyran synthesis for Hep G2 cytotoxicity. Our CDMO expertise enables scalable production with 95%+ yields and cost savings.
Discover a scalable, cost-effective synthesis method for indolocyclopentane compounds with >95% yield and 93% ee. Ideal for pharmaceutical R&D and production of prostate cancer therapeutics.
Discover a cost-effective, air-stable synthesis method for 3-trifluoromethyl-1,2,4-triazole compounds. Eliminate anhydrous/anaerobic requirements, reduce production costs, and ensure consistent supply for your drug development projects.
Discover how ruthenium-catalyzed naphthalene synthesis reduces production costs and supply chain risks for pharmaceutical intermediates and optoelectronic materials. Scale-ready solution.
Solve 2-alkyl quinoline synthesis challenges: 80-92% yield, no anhydrous/oxygen-free, cheap catalysts. Scale with CDMO expertise.
Discover efficient, low-cost synthesis of azacycle-derived polyarylmethane antitumor compounds with >80% yield. Ideal for pharma R&D and production scale-up. Contact us for custom synthesis.
Discover a one-pot, high-yield synthesis method for spirocyclohexadiene pyrazoline with 84-97% yield. Eliminates inert gas needs, reduces costs, and ensures supply chain stability for pharmaceutical intermediates.
Eliminate anhydrous/oxygen-free requirements in furan synthesis. Our CDMO expertise ensures high-yield, cost-effective production of multi-substituted furan intermediates for drug development.